Apart from cancer, the expression of HML2 in neurological disorders such as ALS, Parkinson’s disease, and Alzheimer’s disease (Christensen, 2016; Douville and Nath, 2017; Küry et al., 2018; Dembny et al., 2020; Giménez-Orenga and Oltra, 2021; Kristensen and Christensen, 2021). Here, CLEC10A is linked to cancer.